Masatoshi Tanaka

11.7k total citations
310 papers, 7.9k citations indexed

About

Masatoshi Tanaka is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience and Physiology. According to data from OpenAlex, Masatoshi Tanaka has authored 310 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Cellular and Molecular Neuroscience, 67 papers in Behavioral Neuroscience and 64 papers in Physiology. Recurrent topics in Masatoshi Tanaka's work include Stress Responses and Cortisol (67 papers), Hepatocellular Carcinoma Treatment and Prognosis (56 papers) and Neurotransmitter Receptor Influence on Behavior (39 papers). Masatoshi Tanaka is often cited by papers focused on Stress Responses and Cortisol (67 papers), Hepatocellular Carcinoma Treatment and Prognosis (56 papers) and Neurotransmitter Receptor Influence on Behavior (39 papers). Masatoshi Tanaka collaborates with scholars based in Japan, United States and Canada. Masatoshi Tanaka's co-authors include Akira Tsuda, Masami Yoshida, Yoshishige Ida, Nobuyuki Nagasaki, Hideyasu Yokoo, Yasuko Kohno, Ryoichi Nakagawa, Akira Tsuda, Katsuhiro Mizoguchi and Takahiko Tanaka and has published in prestigious journals such as Gastroenterology, The Science of The Total Environment and Hepatology.

In The Last Decade

Masatoshi Tanaka

303 papers receiving 7.6k citations

Peers

Countries citing papers authored by Masatoshi Tanaka

Since Specialization

Citations

This map shows the geographic impact of Masatoshi Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masatoshi Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masatoshi Tanaka more than expected).

Fields of papers citing papers by Masatoshi Tanaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masatoshi Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masatoshi Tanaka. The network helps show where Masatoshi Tanaka may publish in the future.

Co-authorship network of co-authors of Masatoshi Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Masatoshi Tanaka. A scholar is included among the top collaborators of Masatoshi Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masatoshi Tanaka. Masatoshi Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety of lenvatinib‐transcatheter arterial chemoembolization sequential therapy for hepatocellular carcinoma within the up‐to‐seven criteria 2025 ·Hepatology Research ·Shigeo Shimose, Takashi Niizeki, Hideki Iwamoto, Masatoshi Tanaka, (unknown), Tomotake Shirono, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi	0
2	Efficacy of Atezolizumab Plus Bevacizumab–Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma 2024 ·Current Oncology ·(unknown), Shigeo Shimose, (unknown), Hideki Iwamoto, Masatoshi Tanaka, Tomotake Shirono, Yu Noda, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi	1
3	Telephone follow‐up contributes to improving adherence and treatment duration in patients with hepatocellular carcinoma treated with lenvatinib 2023 ·Journal of Gastroenterology and Hepatology ·(unknown), Shigeo Shimose, Takashi Niizeki, (unknown), Hideki Iwamoto, Masatoshi Tanaka, (unknown), Tomotake Shirono, (unknown), Yu Noda, Masahito Nakano, (unknown), (unknown), Ryoko Kuromatsu, Hironori Koga, Kyoko Higuchi, Takumi Kawaguchi	4
4	Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching 2023 ·International Journal of Molecular Sciences ·Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki, Masatoshi Tanaka, Tomotake Shirono, (unknown), Yu Noda, Masahito Nakano, Hideya Suga, Ryoko Kuromatsu, Takuji Torimura, Hironori Koga, Takumi Kawaguchi	4
5	The impact of curative conversion therapy aimed at a cancer‐free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab 2023 ·Cancer Medicine ·Shigeo Shimose, Hideki Iwamoto, Tomotake Shirono, Masatoshi Tanaka, Takashi Niizeki, (unknown), Satoshi Itano, Yoichi Yano, (unknown), (unknown), Yu Noda, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi	14
6	Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study 2022 ·Cancers ·Shigeo Shimose, Hideki Iwamoto, Masatoshi Tanaka, Takashi Niizeki, (unknown), Satoshi Itano, (unknown), Tomotake Shirono, Yu Noda, Naoki Kamachi, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi	11
7	Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice 2021 ·Cancers ·Hideki Iwamoto, Shigeo Shimose, Yu Noda, Tomotake Shirono, Takashi Niizeki, Masahito Nakano, Shusuke Okamura, Naoki Kamachi, Hiroyuki Suzuki, Miwa Sakai, (unknown), Satoshi Itano, Masatoshi Tanaka, Taizo Yamaguchi, Ryoko Kuromatsu, Hironori Koga, Takuji Torimura, (unknown)	39
8	Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study 2021 ·Cancers ·Shigeo Shimose, Hideki Iwamoto, Masatoshi Tanaka, Takashi Niizeki, Tomotake Shirono, Yu Noda, Naoki Kamachi, Shusuke Okamura, Masahito Nakano, Hideya Suga, Taizo Yamaguchi, Takumi Kawaguchi, Ryoko Kuromatsu, Kazunori Noguchi, Hironori Koga, Takuji Torimura	37
9	Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumab 2020 ·British Journal of Urology ·Wataru Fukuokaya, Takahiro Kimura, Takafumi Yanagisawa, Shoji Kimura, Shunsuke Tsuzuki, (unknown), (unknown), (unknown), Masatoshi Tanaka, Fumihiko Urabe, (unknown), Mariko Honda, Jun Miki, Yu Oyama, Hirokazu Abe, Shin Egawa	5
10	Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study 2020 ·Cancers ·Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki, Tomotake Shirono, Yu Noda, Naoki Kamachi, Shusuke Okamura, Masahito Nakano, Hideya Suga, Ryoko Kuromatsu, Taizo Yamaguchi, Takumi Kawaguchi, Masatoshi Tanaka, Kazunori Noguchi, Hironori Koga, Takuji Torimura	54
11	Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Cohort Study 2020 ·Nutrients ·Shigeo Shimose, Takumi Kawaguchi, Hideki Iwamoto, Masatoshi Tanaka, Kentaro Miyazaki, (unknown), Takashi Niizeki, Tomotake Shirono, Shusuke Okamura, Masahito Nakano, Hideya Suga, Taizo Yamaguchi, Yoshinori Yokokura, Kazunori Noguchi, Hironori Koga, Takuji Torimura	33
12	Double-blind, controlled study to evaluate safety and efficacy of doripenem and meropenem in patients with complicated urinary tract infection 2005 ·Sadao Kamidono, Soichi Arakawa, Takaoki Hirose, Hiroichi Kishi, Masaya Tsugawa, Tetsuro Matsumoto, Masatoshi Tanaka, Motoshi Kawahara, Mitsuyoshi Nakashima, (unknown), Jingoro Shimada	3
13	Clinical study of tosufloxacin tosilate in the treatment of non-gonococcal urethritis 1993 ·Chemotherapy ·Takashi Deguchi, Yukimichi Kawada, Isao Saito, (unknown), Soichi Arakawa, Sadao Kamidono, Masatoshi Tanaka, Joichi Kumazawa	5
14	The cortical dopaminergic innervation as observed by immunohistochemistry using antiserum against dopamine in the rat brain 1987 ·ACTA HISTOCHEMICA ET CYTOCHEMICA ·Masami Yoshida, Ikuko Nagatsu, Toshiharu Nagatsu, Masatoshi Tanaka	2
15	Changes in Averaged Photopalpebral Reflex in Man by A New Benzodiazepine Derivative 1981 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Masatoshi Tanaka, Hiroshi Isozaki, Yasushi Mizuki, Akira Tsuda, Kazutoyo Inanaga	4
16	EFFECTS ON THE MANUAL FUNCTION OF MEN WEARING COLD-PROTECTIVE CLOTHING TO COLD STRESS 1981 ·Masatoshi Tanaka, (unknown), Yutaka Tochihara, Tadakatsu Ohnaka, Shinya Yamazaki, Keiichi Yoshida, (unknown)	3
17	Effects of Triazolam and Nitrazepam on the Averaged Photopalpebral Reflex in Man 1979 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Masatoshi Tanaka, Hiroshi Isozaki, Yasushi Mizuki, Kazutoyo Inanaga, (unknown)	3
18	Prolongation of the Peak Latencies of the Averaged 1977 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Masatoshi Tanaka, Hiroshi Isozaki, Kazutoyo Inanaga	3
19	The Effect of Antianxiety Agent (medazepam) for Essential Hypertensions 1974 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Nobuya Ogawa, (unknown), Tsuyoshi Yamaguchi, (unknown), Toshiie Sakata, (unknown), Hiromitsu Tanaka, Yoshifumi Toyama, Shigeyuki Nakano, Masatoshi Tanaka, Masashi Goto, (unknown)	2
20	Study of L-Glutamic Acid Fermentation (II) : Bacteriological Study of L-Glutamic Acid Producing Baceria (I) : Taxonomic Study of Brevibacterium aminogenes nov. spec. 1959 ·Journal of Fermentation Technology ·Shuji Ota, Masatoshi Tanaka	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact